SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850693-14-000008
Filing Date
2014-11-05
Accepted
2014-11-04 20:02:06
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q agn10-qq32014.htm 10-Q 2101635
2 EXHIBIT 10.1 agnex101q32014.htm EX-10.1 136506
3 EXHIBIT 31.1 agnex311q32014.htm EX-31.1 12052
4 EXHIBIT 31.2 agnex312q32014.htm EX-31.2 12458
5 EXHIBIT 32 agnex32q32014.htm EX-32 12572
12 eximage1a01.jpg GRAPHIC 11593
  Complete submission text file 0000850693-14-000008.txt   11782266

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT agn-20140930.xml EX-101.INS 1973173
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agn-20140930.xsd EX-101.SCH 63531
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agn-20140930_cal.xml EX-101.CAL 100430
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agn-20140930_def.xml EX-101.DEF 246935
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agn-20140930_lab.xml EX-101.LAB 824078
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agn-20140930_pre.xml EX-101.PRE 426225
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10269 | Film No.: 141194713
SIC: 2834 Pharmaceutical Preparations